Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genprex, Inc. - Common Stock (NQ:GNPX)

0.2786 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genprex, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Hoth Therapeutics (NASDAQ: 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Oncology R&D Pipeline to Include Small Cell Lung Cancer
Via Investor Brand Network
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
From Genprex, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Indaptus Therapeutics (NASDAQ:INDP 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million... 
Via Benzinga
CCL Stock: Why Carnival Is Cruising Higher Despite the CDC’s Covid Call
Carnival (CCL) stock is heading higher on Monday despite recent concerns about the Covid-19 Omicron variant and CDC warnings. 
Via InvestorPlace
TSM Stock: What Investors Are Saying About the Taiwan Semiconductor Breakout Today
Taiwan Semiconductor (TSM) stock is getting a nice boost today alongside heavy trading even without any news surrounding the company today. 
Via InvestorPlace
Dow Flat as Tesla Lifts Tech, Autos
The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black. 
Via Talk Markets
GNPX Stock: 5 Things to Know as Genprex Rockets Higher
Shares of GNPX stock are soaring higher after the FDA granted fast track designation (FTD) for the company's lead drug candidate, REQORSA. 
Via InvestorPlace
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. 
Via InvestorPlace
Why Genprex Shares Are Soaring Today
Genprex Inc (NASDAQ: GNPX) is trading higher Monday after the company announced it received U.S. Food and Drug Administration Fast Track Designation (FTD) for REQORSA... 
Via Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Granted Fast Track Designation for Proprietary Immunogene Therapy from FDA
Via Investor Brand Network
Exposures Product Safety
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
The FDA has granted Fast Track Designation for Genprex Inc's (NASDAQ: GNPX) lead drug candidate, Reqorsa Immunogene combination therapy. The designation... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million.... 
Via Benzinga
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
From Genprex, Inc.
Via Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO to Present in CEO Roadshow Webinar
Via Investor Brand Network
Genprex to Present in November CEO Roadshow Webinar
From Genprex, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tenet Healthcare (NYSE:THC) stock r... 
Via Benzinga
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Strengthens Management Team with Strategic Appointments
Via Investor Brand Network
Genprex Strengthens Management Team with Appointments of Industry Leaders Mark S. Berger, M.D. as Chief Medical Officer and Hemant Kumar, Ph.D. as Chief Manufacturing and Technology Officer
From Genprex, Inc.
Via Business Wire
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Two Upcoming Investor Conferences
Via Investor Brand Network
Genprex to Participate in September Investor Conferences
From Genprex, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers MorphoSys (NASDAQ:MOR) stock move... 
Via Benzinga
Genprex to Participate in a Monthly CEO Roadshow Webinar Series
From Genprex, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.